Vital Therapies (VTL) Tops Q3 EPS by 2c

Vital Therapies (NASDAQ: VTL) reported Q3 EPS of ($0.30), $0.02 better than the analyst estimate of ($0.32).

For earnings history and earnings-related data on Vital Therapies (VTL) click here.

You May Also Be Interested In

• NIO Inc. (NIO) Tops Q2 EPS by 33c; offers guidance
• MongoDB (MDB) Tops Q2 EPS by 29c, Beats on Revenue; Offers FY37 Guidance
• EU opens antidumping review of Chinese silicon metal imports